07:00 , May 18, 2015 |  BC Week In Review  |  Company News

Actavis, TPG Capital deal

Actavis completed the divestiture of its Aptalis Pharmaceutical Technologies subsidiary to private investment firm TPG for an undisclosed sum. Aptalis said that its new name is Adare Pharmaceuticals (see BioCentury, Feb. 16). Actavis Group, Zug,...